Authors:
Griese, EU
Ilett, KF
Kitteringham, NR
Eichelbaum, M
Powell, H
Spargo, RM
LeSouef, PN
Musk, AW
Minchin, RF
Citation: Eu. Griese et al., Allele and genotype frequencies of polymorphic cytochromes P4502D6, 2C19 and 2E1 in Aborigines from Western Australia, PHARMACOGEN, 11(1), 2001, pp. 69-76
Authors:
Lohmann, PL
Rao, ML
Ludwig, M
Griese, EU
Zanger, UM
Morike, K
Maier, W
Bagli, M
Citation: Pl. Lohmann et al., Influence of CYP2D6 genotype and medication on the sparteine metabolic ratio of psychiatric patients, EUR J CL PH, 57(4), 2001, pp. 289-295
Authors:
Raimundo, S
Fischer, R
Eichelbaum, M
Griese, EU
Schwab, M
Zanger, UM
Citation: S. Raimundo et al., Elucidation of the genetic basis of the common 'intermediate metabolizer' phenotype for drug oxidation by CYP2D6, PHARMACOGEN, 10(7), 2000, pp. 577-581
Authors:
Griese, EU
Asante-Poku, S
Ofori-Adjei, D
Mikus, G
Eichelbaum, M
Citation: Eu. Griese et al., Analysis of the CYP2D6 gene mutations and their consequences for enzyme function in a West African population, PHARMACOGEN, 9(6), 1999, pp. 715-723
Authors:
Jorge, LF
Eichelbaum, M
Griese, EU
Inaba, T
Arias, TD
Citation: Lf. Jorge et al., Comparative evolutionary pharmacogenetics of CYP2D6 in Ngawbe and Embera Amerindians of Panama and Colombia: role of selection versus drift in world populations, PHARMACOGEN, 9(2), 1999, pp. 217-228
Authors:
Ammon, S
Hofmann, U
Griese, EU
Gugeler, N
Mikus, G
Citation: S. Ammon et al., Pharmacokinetics of dihydrocodeine and its active metabolite after single and multiple oral dosing, BR J CL PH, 48(3), 1999, pp. 317-322